Corvus Pharmaceuticals, Inc. (CRVS)

17.14 +1.60 (+10.30%) USD  |  NASDAQ  |  Apr 21, 16:00
17.03 -0.11 (-0.64%) After-Hours: 20:00
More

Corvus Pharmaceuticals Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for CRVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Nektar Therapeutics Upgrade
Jaguar Health, Inc. Upgrade